https://www.live-feeds.com/feed/germany-s-merck-boosts-life-sciences-business-with-11-billion-bio-techne-dealContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/germany-s-merck-boosts-life-sciences-business-with-11-billion-bio-techne-dealhttps://www.live-feeds.com/feed/germany-s-merck-boosts-life-sciences-business-with-11-billion-bio-techne-deal#u18298Tue, 30 Jun 2026 04:36:58 +0000German drugmaker Merck KGaA has agreed to purchase U.S.-based Bio-Techne Corp. The deal aims to strengthen Merck's position in life sciences and advanced biological research markets. This represents the company's largest acquisition in more than ten years.What's confirmed:Merck KGaA agreed to acquire U.S. biotech firm Bio-Techne Corp for $11.3 billion.The purchase price is US$73 per share in cash, representing an enterprise value of EUR 9.9 billion.This is the largest deal for Merck KGaA in over a decade.Bio-Techne is based in the Twin Cities.Still unconfirmed:The deal follows the re